Prof Marc Brown has over 30 years experience in topical (skin, nail, eye, lung, nose and other mucousal membranes) and transdermal formulation development in the pharmaceutical development sector. After working in North America for a few years , in 1999 he co-founded MedPharm and, as CSO, was the guiding force behind all of MedPharm’s scientific developments and intellectual property until its sale in 2022. He has been Professor of Pharmaceutics and Toxicology in the School of Pharmacy, University of Hertfordshire since 2006 , has visiting/honorary professorships at the Universities of Reading and King’s College London and was awarded Professor Emeritus status in 2022 . His research interests lie mainly in drug delivery to the skin, nail and airways and has one text book, over 200 publications and 30 patents describing his work. To date, he has been involved in the pharmaceutical development of over 55 medicinal products that are now on the market in Europe, America and Japan. He currently acts as CSO of Mosanna Therapeutics AG, is a scientific advisor for numerous pharma companies and has been an expert witness in various patent litigation cases in the US and Europe.

Margarida Miranda graduated in Pharmaceutical Sciences (University of Lisbon) and completed her PhD in Pharmaceutical Technology (University of Coimbra, Portugal) and has published 18 papers, 4 book chapters and edited 1 book on the field of topical drug delivery. After completing her Ph.D she translated her research into the R&D department of Laboratórios Basi, where she has implemented IVRT/IVPT methods within a Quality Management System. In addition, she actively contributed to the definition of strategies to demonstrate topical bioequivalence, in accordance with the current European and American guidelines and has been involved in the development, submission and approval of several topical generic products in the European market. Whilst consulting for MLBT she is also Assistant Professor of Pharmaceutical Technology, as well as Cosmetic Science, at Egas Moniz School of Health and Science.

Adrian Williams has worked in medicinal product and device design and development and drug delivery since the late 80’s when he undertook his PhD in transdermal drug delivery under the supervision of Professor Brian Barry at the University of Bradford.  Following his PhD, he was appointed to the academic staff in the School and progressed to Professor of Biophysical Pharmaceutics,  working on topical formulation development   and many other aspects of pharmaceutics, biophysical characterisation and bioequivalence.  In 2004 he moved to the new School of Pharmacy at the University of Reading as Professor of Pharmaceutics and subsequently as the Head of the School of Pharmacy, before taking Dean and, most recently,  Associate Pro-Vice Chancellor roles.  He continues to research extensively in topical and transdermal drug delivery, in addition to mucoadhesive formulation development, ocular, otic and nasal drug delivery and polymeric systems.  His research is disseminated in > 200 publications including books and book chapters, review articles and original research papers alongside multiple national and international conference with his achievements recognised by the award of a Higher Doctorate in 2025.  He has worked extensively with the pharmaceutical industry on drug/product development  and sat on Scientific Advisory or other Boards for pharmaceutical and personal care companies and NHS organisations, and acted as expert witness in many patent litigation matters.